Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T10172 | 5-Iodo-indirubin-3'-monoxime | 331467-03-9 | 98% |
|
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s:... | ||||
T13309 | Voruciclib hydrochloride | 1000023-05-1 | 98% |
|
Voruciclib hydrochloride is an orally active and selective inhibitor of CDK (Ki: 0.626 nM-9.1 nM). | ||||
TMA1743 | Ergosterol peroxide | 2061-64-5 | 98% |
|
Ergosterol peroxide is an inhibitor of osteoclast differentiation, which has antiviral, trypanocidal, antitumor, and antiangiogenic actions, it can stimulate Fox... | ||||
T72507 | Palbociclib orotate | 2757498-64-7 | 98% |
|
Palbociclib (PD 0332991) orotate, an orally active selective inhibitor of CDK4 and CDK6, exhibits IC50 values of 11 and 16 nM, respectively. This compound demons... | ||||
T74852 | PROTAC CDK9 degrader-6 | 2935587-91-8 | 98% |
|
PROTAC CDK9 degrader-6 is a specific PROTAC targeting CDK9 that mediates its degradation through the proteasome pathway. This compound effectively degrades CDK9 ... | ||||
T2082 | CDK4-IN-1 | 1256963-02-6 | 98% |
|
CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM; 1500 and 500 fold than CDK1/Cyclin B (IC50>15 uM) and CDK2/Cyclin A (IC50=... | ||||
T13627 | CP-10 | 2366268-80-4 | 98% |
|
CP-10 is a PROTAC with highly selective and remarkable CDK6 degradation (DC50: 2.1 nM). It inhibits the proliferation of several hematopoietic cancer cells inclu... | ||||
T10724 | Cdc7-IN-1 | 1402055-25-7 | 98% |
|
Cdc7-IN-1 is a highly selective and ATP competitive inhibitor of Cdc7 kinase (IC50: 0.6 nM at 1 mM ATP). It potently inhibits Cdc7 activity in cancer cells and e... | ||||
T67780 | AM5992 | 1169694-98-7 | 98% |
|
AM5992 (example 195) is a potent CDK4 and CDK6 inhibitor (CDK4, IC50= 0.013 μM). AM5992 can be used for the research of CDK4-mediated disorders. | ||||
TN4411 | Lappaol F | 69394-17-8 | 98% |
|
1. Lappaol F has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. 2. Lap... |
||||
TN3719 | Cristacarpin | 74515-47-2 | 98% |
|
Cristacarpin exhibits moderate but selective activity towards DNA repair-deficient yeast mutants. It promotes endoplasmic reticulum (ER) stress, leading to sub-l... | ||||
T11345 | Lerociclib | 1628256-23-4 | 98% |
|
Lerociclib (G1T38) is a potent and selective inhibitor of CDK4/6, with IC50s of 2nM, 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively. | ||||
T11632 | IIIM-290 | 2213468-64-3 | 98% |
|
IIIM-290 is an oral CDK inhibitor (IC50s: 90 and 94 nM for CDK2/A and CDK9/T1). | ||||
T10747 | CDK9-IN-9 | 2246956-84-1 | 98% |
|
CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM). | ||||
T12552 | PROTAC CDK2/9 Degrader-1 | 2408641-24-5 | 98% |
|
PROTAC CDK2/9 Degrader-1 is a potent CDK2 and CDK9 dual degrader(DC50 of 62 nM and 33 nM). | ||||
T10741 | CDK9-IN-1 | 1415559-43-1 | 98% |
|
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1). | ||||
T14136 | AG-024322 | 837364-57-5 | 98% |
|
AG-024322 is a potent ATP-competitive inhibitor of pan-CDK against cell cycle kinases CDK1, CDK2, and CDK4(Ki values in the 1-3 nM range) | ||||
T10743 | CDK9-IN-11 | 2748368-15-0 | 98% |
|
CDK9-IN-11 is a potent CDK9 inhibitor that is the ligand for the PROTAC CDK9 Degrader-1 [1]. | ||||
TN3247 | 7-O-Prenylscopoletin | 13544-37-1 | 98% |
|
7-O-Prenylscopoletin and cedrelopsin show high antiproliferative activities against cancer cell lines. | ||||
T14990 | CDK12-IN-3 | 2220184-50-7 | 98% |
|
CDK12-IN-3 is a selective CDK12 inhibitor (IC50: 491 nM in an enzymatic assay). |